COMMUNIQUÉS West-GlobeNewswire

Galapagos increases share capital through warrant exercises
19/09/2019
Mechelen, Belgium; 19 September 2019, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 301,745 new [...]
Transparency notification
19/09/2019
Mechelen, Belgium; 19 september 2019; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Sands Capital Management, LLC . Pursuant to Belgian [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
19/09/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
19/09/2019
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
19/09/2019
SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announces it [...]
Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
19/09/2019
Study Uses NGS Data with Biosimulation to Predict Drug Response in AML and MDS Patients SAN FRANCISCO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of [...]
Genkyotex Announces First Half 2019 Results
19/09/2019
Final setanaxib phase 2 results in PBC showed statistical significance for primary endpoint when corrected for non-normal variability Data to be presented at an upcoming international scientific conference WHO [...]
Genkyotex publie ses résultats semestriels 2019
19/09/2019
Les résultats complets de l’essai clinique de phase 2 avec le setanaxib en CBP montrent une différence statistiquement significative du paramètre principal après correction des aberrations de distribution Présentation [...]
Valneva Confirms Delisting from the Vienna Stock Exchange
19/09/2019
Valneva Confirms Delisting from the Vienna Stock Exchange Last VSE trading day will take place on December 20, 2019 Valneva shares will be automatically transferred to Euronext Paris Valneva’s listing on Euronext Paris [...]
Valneva confirme le retrait de ses actions de la Bourse de Vienne
19/09/2019
Valneva confirme le retrait de ses actions de la Bourse de Vienne Dernier jour de cotation des actions à la bourse de Vienne (VSE) le 20 décembre 2019 Les actions Valneva seront automatiquement transférées sur Euronext [...]
PSIQ Terminates Letter of Intent to Acquire Ecoland
19/09/2019
SUNRISE, Fla., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC: PSIQ) announces that effective August 21 st 2019, the letter of intent dated April 27 th 2019 to acquire 80% of Ecoland K.K.L. LTD and [...]
BrainsWay Announces Further Leadership Transition to U.S.
19/09/2019
Company Intends to Appoint U.S.-Based CEO JERUSALEM and HACKENSACK, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced, non- [...]
Veterans Affairs Northeast Ohio Healthcare System Receives Spinal Cord Rehabilitation Exoskeleton from SoldierStrong
19/09/2019
CLEVELAND, Sept. 19, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing revolutionary medical technologies to help injured veterans lead full lives, donated an Indego [...]
BriaCell Announces Public Disclosure: Remarkable Responder in Combination Study of Lead Candidate with KEYTRUDA®
19/09/2019
Material information is being presented concurrent with this press release at 9:35am Eastern Time at the Next Gen Immuno-Oncology Congress. Publicly-traded securities of BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB: [...]
MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD
19/09/2019
WESTLAKE VILLAGE, Calif., Sept. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced that data from a one-year study of Afrezza® (insulin human) Inhalation Powder was presented at the 55 th Annual [...]
Aptevo Therapeutics Introduces New Adaptir™ Bispecific Antibody Candidate Intended for the Treatment of Solid Tumors
19/09/2019
New ADAPTIR Candidate APVO603 is a Dual-Agonistic Bispecific Antibody Targeting 4-1BB and OX40 APVO603 is Designed to Induce Synergistic Effects on Immune Responses with Potential to Enhance Anti-Tumor Immune Response [...]
INSTI now available for expanded point-of-care use in Canada
19/09/2019
The world’s fastest HIV test is more accessible than ever before as Health Canada approves revised Intended Use statement. RICHMOND, British Columbia, Sept. 19, 2019 (GLOBE NEWSWIRE) -- bioLytical Laboratories , a world [...]
Rafael Pharmaceuticals Announces Expansion into South Korea of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
19/09/2019
CRANBURY, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that the Phase 3 [...]
HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris
19/09/2019
NEW YORK and VIENNA, Austria, Sept. 19, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on [...]

Pages